CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Ulipristal

乌利司他 杂质对照品Ulipristal Impurities

28 个杂质条目28 impurity entries

本页汇总 乌利司他 的 28 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 28 impurity reference standards of Ulipristal. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 乌利司他(Ulipristal)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesOptimization and Validation of HPTLC Method for Estimation of Ulipristal Acetate in Presence of Its Forced Degradation Products
    Journal of chromatographic science · 2020 · Kamdar G, Desai S  ·  PMID 32163148  ·  DOI
  2. 分析方法Analytical MethodsA novel LC-MS/MS method for the quantification of ulipristal acetate in human plasma: Application to a pharmacokinetic study in healthy Chinese female subjects
    International journal of clinical pharmacology and therapeutics · 2020 · Peng C et al.  ·  PMID 32990217  ·  DOI
  3. 分析方法Analytical MethodsA UPLC-MS/MS method for the quantitation of Ulipristal acetate in human serum
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2017 · Nandakumar R et al.  ·  PMID 28570936  ·  DOI
  4. 分析方法Analytical MethodsDispersive solvent-free ultrasound-assisted ionic liquid dispersive liquid-liquid microextraction coupled with HPLC for determination of ulipristal acetate
    Talanta · 2015 · Gong A, Zhu X  ·  PMID 25281147  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisA new and efficient method for the synthesis of Ulipristal acetate
    Steroids · 2014 · Cheng X et al.  ·  PMID 24686204  ·  DOI

乌利司他 —— 原料药与杂质对照品Ulipristal — drug substance & impurities

共 29 个条目(含原料药本体)29 items incl. the drug substance
Ulipristal structure
原料药 APIAPI
乌利司他Ulipristal
Ulipristal
CAS No.159811-51-5
Chemical FormulaC28H35NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 1 structure
1
乌利司他杂质1Ulipristal Impurity 1
Ulipristal Impurity 1
CAS No.1926157-81-4
Chemical FormulaC24H28O5
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 2 structure
2
乌利司他杂质2Ulipristal Impurity 2
Ulipristal Impurity 2
CAS No.1948217-10-4
Chemical FormulaC24H30O6
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 3 structure
3
乌利司他杂质3Ulipristal Impurity 3
Ulipristal Impurity 3
CAS No.1948217-14-8
Chemical FormulaC22H28O5
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 4(N-Desmethyl Ulipristal Acetate) structure
4
乌利司他杂质4(N-去甲基醋酸乌利司他)Ulipristal Impurity 4(N-Desmethyl Ulipristal Acetate)
Ulipristal Impurity 4(N-Desmethyl Ulipristal Acetate)
CAS No.159681-66-0
Chemical FormulaC29H35NO4
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 5 structure
5
乌利司他杂质5Ulipristal Impurity 5
Ulipristal Impurity 5
CAS No.1655514-84-3
Chemical FormulaC30H37NO4
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 6 structure
6
乌利司他杂质6Ulipristal Impurity 6
Ulipristal Impurity 6
CAS No.1927849-73-7
Chemical FormulaC32H39NO5
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 8 structure
8
乌利司他杂质8Ulipristal Impurity 8
Ulipristal Impurity 8
CAS No.1926157-83-6
Chemical FormulaC26H32O6
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 9 structure
9
乌利司他杂质9Ulipristal Impurity 9
Ulipristal Impurity 9
CAS No.1926157-84-7
Chemical FormulaC32H37NO5
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 10 structure
10
乌利司他杂质10Ulipristal Impurity 10
Ulipristal Impurity 10
CAS No.1926157-85-8
Chemical FormulaC30H35NO4
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 11 structure
11
乌利司他杂质11Ulipristal Impurity 11
Ulipristal Impurity 11
CAS No.1927850-00-7
Chemical FormulaC30H37NO5
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 13 structure
13
乌利司他杂质13Ulipristal Impurity 13
Ulipristal Impurity 13
CAS No.54201-84-2
Chemical FormulaC24H34O5
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 14 structure
14
乌利司他杂质14Ulipristal Impurity 14
Ulipristal Impurity 14
CAS No.586-77-6
Chemical FormulaC8H10BrN
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 15 structure
15
乌利司他杂质15Ulipristal Impurity 15
Ulipristal Impurity 15
CAS No.54201-83-1
Chemical FormulaC24H34O6
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 16 structure
16
乌利司他杂质16Ulipristal Impurity 16
Ulipristal Impurity 16
CAS No.126690-41-3
Chemical FormulaC32H45NO6
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 17 structure
17
乌利司他杂质17Ulipristal Impurity 17
Ulipristal Impurity 17
CAS No.2589859-36-7
Chemical FormulaC32H39NO5
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 18 structure
18
乌利司他杂质18Ulipristal Impurity 18
Ulipristal Impurity 18
CAS No.244206-56-2
Chemical FormulaC31H37NO5
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 19 structure
19
乌利司他杂质19Ulipristal Impurity 19
Ulipristal Impurity 19
CAS No.709615-25-8
Chemical FormulaC30H37NO4
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 20 structure
20
乌利司他杂质20Ulipristal Impurity 20
Ulipristal Impurity 20
CAS No.159681-67-1
Chemical FormulaC27H33NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 21 structure
21
乌利司他杂质21Ulipristal Impurity 21
Ulipristal Impurity 21
CAS No.244206-52-8
Chemical FormulaC26H31NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 22 structure
22
乌利司他杂质22Ulipristal Impurity 22
Ulipristal Impurity 22
CAS No.244206-49-3
Chemical FormulaC28H33NO4
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 24 structure
24
乌利司他杂质24Ulipristal Impurity 24
Ulipristal Impurity 24
CAS No.1655514-73-0
Chemical FormulaC28H35NO3
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 26 structure
26
乌利司他杂质26Ulipristal Impurity 26
Ulipristal Impurity 26
CAS No.1655514-74-1
Chemical FormulaC30H37NO4
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 27 structure
27
乌利司他杂质27Ulipristal Impurity 27
Ulipristal Impurity 27
CAS No.1926157-82-5
Chemical FormulaC30H37NO4
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 28 structure
28
乌利司他杂质28Ulipristal Impurity 28
Ulipristal Impurity 28
CAS No.1655514-76-3
Chemical FormulaC30H37NO4
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 29 structure
29
乌利司他杂质29Ulipristal Impurity 29
Ulipristal Impurity 29
CAS No.244206-51-7
Chemical FormulaC30H41NO6
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 30 structure
30
乌利司他杂质30Ulipristal Impurity 30
Ulipristal Impurity 30
CAS No.2338825-26-4
Chemical FormulaC32H45NO6
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 34 structure
34
乌利司他杂质34Ulipristal Impurity 34
Ulipristal Impurity 34
CAS No.1655514-78-5
Chemical FormulaC20H26O3
Purity>95%询价On request
10mg25mg50mg100mg
Ulipristal Impurity 37 structure
37
乌利司他杂质37Ulipristal Impurity 37
Ulipristal Impurity 37
CAS No.730962-28-4
Chemical FormulaC32H43NO6
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

乌利司他 —— 研究文献与合成路线Ulipristal — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 乌利司他 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Ulipristal. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Optimization and Validation of HPTLC Method for Estimation of Ulipristal Acetate in Presence of Its Forced Degradation Products
    Kamdar G, Desai S · Journal of chromatographic science · 2020 · 被引 1cited 1

合成路线文献Synthetic-route papers

  1. A simple and convenient synthetic route to Ulipristal acetate
    Yu Y, He Y, Zhao Y, et al. · Steroids · 2013
  2. First synthesis and characterization for the stereoisomers of Ulipristal acetate
    Zhao Y, Li X, Liu H, et al. · Steroids · 2015
  3. A new and efficient method for the synthesis of Ulipristal acetate
    Cheng X, Li X, Duan Y, et al. · Steroids · 2014

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

乌利司他 杂质谱研究要点Ulipristal — impurity profiling notes

下面这些是拿到 乌利司他 的 29 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 29 impurity entries for Ulipristal, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances